Dr Chui Yan Mah
Postdoctoral Research Fellow
South Australian Immunogenomics Cancer Institute
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.
Dr Shanice Mah (PhD) is a Postdoctoral Research Fellow at the University of Adelaide, based at the South Australian Health and Medical Research Institute (SAHMRI). She graduated with a Bachelor of Science (Biomedical Science) from the University of Adelaide in 2016 and was awarded a Master of Philosophy (No Honours) International Scholarship to pursue a Doctor of Philosophy in Medicine. Shanice graduated with a PhD in 2021 and is currently a recipient of the Prostate Cancer Foundation of Australia Future Leaders Award for her research focused on developing new therapies for prostate cancer.
-
Appointments
Date Position Institution name 2023 - ongoing Cancer Council SA Beat Cancer Project Early Career Research Fellow University of Adelaide 2022 - 2023 Prostate Cancer Foundation of Australia Research Fellow University of Adelaide 2021 - 2022 Research Officer University of Adelaide -
Awards and Achievements
Date Type Title Institution Name Country Amount 2023 Award AACR-Prostate Cancer Foundation Scholar-in-Training Award American Association for Cancer Research (AACR) United States $1900 USD 2022 Nomination 7News Young Achiever's Award Semi-Finalist 7News South Australia Australia - 2022 Fellowship Prostate Cancer Foundation of Australia Future Leaders Award Prostate Cancer Foundation of Australia Australia $100,000 2021 Award 2021 Merdeka Award Australia Malaysia Business Council SA Inc Australia $1000 2020 Recognition Ross Wishart Memorial Award Finalist Australian Society for Medical Research Australia - 2020 Award John Barker Bequest Prize in Cancer Research University of Adelaide Australia - 2019 Award People's Choice PhD Oral Presentation Award Australian Society for Medical Research Australia - 2017 Award Platinum Level of Sponsorship for ABACBS and COMBINE Student Symposium University of Adelaide Australia - 2017 Achievement Selection for the 4th Annual EMBL Australia PhD course, 2017 EMBL Australia Australia - 2017 Scholarship Freemasons Centre for Male Health and Wellbeing Top-Up Scholarship Freemasons Foundation Centre for Men's Health Australia - 2017 Scholarship Master of Philosophy (No Honours) International Scholarship The University of Adelaide Australia - 2016 Scholarship Adelaide Summer Research Scholarship 2016 The University of Adelaide Australia - 2015 Scholarship Adelaide Summer Research Scholarship 2015 The University of Adelaide Australia - 2015 Award Outstanding Academic Achievement Award 2015 & 2016 The University of Adelaide Australia - -
Language Competencies
Language Competency Chinese (Cantonese) Can read, write, speak and understand spoken Chinese (Mandarin) Can read, write, speak and understand spoken English Can read, write, speak and understand spoken Malay Can read, write, speak and understand spoken -
Education
Date Institution name Country Title 2017 - 2021 The University of Adelaide Australia Doctor of Philosophy (Medicine) 2015 - 2016 The University of Adelaide Australia Bachelor of Science (Biomedical Science) -
Research Interests
-
Journals
Year Citation 2024 Mah, C. Y., Nguyen, A. D. T., Niijima, T., Helm, M., Dehairs, J., Ryan, F. J., . . . Butler, L. M. (2024). Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer. British Journal of Cancer, 130(5), 741-754.
Scopus1 Europe PMC12023 Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Tables S2-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
2023 Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Table S1 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
2023 Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S2 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
2023 Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S1 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
2023 Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Supplementary Figures and Legends 1-8 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
2023 Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Figures S1-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
2023 Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S2 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
2023 Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Figures S1-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
2023 Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Data from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
2023 Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Data from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
2023 Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S1 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
2023 Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S3 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
2023 Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S3 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
2023 Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Data from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
2023 Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Tables S2-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
2023 Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S4 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
2023 Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Table S4 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
2023 Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (2023). Supplementary Table S1 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
2023 Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2023). Supplementary Figures and Legends 1-8 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
2023 Centenera, M. M., Scott, J. S., Machiels, J., Nassar, Z. D., Miller, D. C., Zinonos, I., . . . Butler, L. M. (2023). Data from ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.
2023 Centenera, M. M., Scott, J. S., Machiels, J., Nassar, Z. D., Miller, D. C., Zinonos, I., . . . Butler, L. M. (2023). Supplementary Data from ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.
2023 Centenera, M. M., Scott, J. S., Machiels, J., Nassar, Z. D., Miller, D. C., Zinonos, I., . . . Butler, L. M. (2023). Supplementary Data from ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.
2023 Hinneh, J. A., Gillis, J. L., Mah, C. Y., Irani, S., Shrestha, R. K., Ryan, N. K., . . . Butler, L. M. (2023). Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer. British Journal of Cancer, 129(8), 1350-1361.
2021 Schjenken, J. E., Green, E. S., Overduin, T. S., Mah, C. Y., Russell, D. L., & Robertson, S. A. (2021). Endocrine disruptor compounds-a cause of impaired immune tolerance driving inflammatory disorders of pregnancy?. Frontiers in Endocrinology, 12, 607539-1-607539-15.
Scopus32 WoS20 Europe PMC142021 Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S., . . . Swinnen, J. V. (2021). Lipidomic profiling of clinical prostate cancer reveals targetable alterations in membrane lipid composition. Cancer Research, 81(19), 4981-4993.
Scopus36 WoS26 Europe PMC302021 Tangseefa, P., Martin, S. K., Chin, P. Y., Breen, J., Mah, C. Y., Baldock, P. A., . . . Zannettino, A. C. W. (2021). The mTORC1 complex in pre-osteoblasts regulates whole-body energy metabolism independently of osteocalcin. Bone Research, 9(1), 10-1-10-17.
Scopus3 WoS3 Europe PMC32021 Centenera, M. M., Scott, J. S., Machiels, J., Nassar, Z. D., Miller, D. C., Zinonos, I., . . . Butler, L. M. (2021). ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer. Cancer Research, 81(7), 1704-1718.
Scopus38 WoS36 Europe PMC282020 Mah, C. Y., Nassar, Z. D., Swinnen, J. V., & Butler, L. M. (2020). Lipogenic effects of androgen signaling in normal and malignant prostate. Asian Journal of Urology, 7(3), 258-270.
Scopus22 WoS18 Europe PMC142020 Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2020). Fatty acid oxidation is an adaptive survival pathway induced in prostate tumors by heat shock protein 90 inhibition. Molecular cancer research : MCR, 18(10), 1500-1511.
Scopus11 WoS10 Europe PMC82020 Nassar, Z. D., Mah, C. Y., Dehairs, J., Burvenich, I. J., Irani, S., Centenera, M. M., . . . Butler, L. M. (2020). Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis. Elife, 9, 1-34.
Scopus83 WoS70 Europe PMC532020 Asari, P., Roscioli, E., Hurtado, P., Tran, H., Mah, C., & Hodge, S. (2020). LC3-associated phagocytosis (LAP): a potentially influential mediator of efferocytosis-related tumour progression and aggressiveness.. Frontiers in Oncology-Molecular and Cellular Oncology, 10, 14 pages.
Scopus23 WoS20 Europe PMC132019 Nassar, Z. D., Mah, C. Y., Dehairs, J., Burvenich, I. J. G., Irani, S., Centenera, M. M., . . . Butler, L. M. (2019). DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis.
2018 Nassar, Z., Aref, A., Miladinovic, D., Mah, C., Raj, G., Hoy, A., & Butler, L. (2018). Peri-prostatic adipose tissue: the metabolic microenvironment of prostate cancer. BJU International, 121(Suppl. 3), 9-21.
Scopus56 WoS51 Europe PMC39 -
Conference Items
Year Citation 2023 Cilento, M. A., Mah, C. Y., Martelotto, L., Sweeney, C. J., & Butler, L. M. (2023). Multiomic analysis workflow for biomarker discovery in human prostate cancer. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY. 2020 Butler, L. M., Mah, C. Y., Dehairs, J., Vincent, A., Mutuku, S., Spotbeen, X., . . . Swinnen, J. (2020). Phospholipid profiling of clinical prostate tissues reveals targetable alterations in membrane lipid composition accompanying tumorigenesis. Poster session presented at the meeting of CANCER RESEARCH. ELECTR NETWORK: AMER ASSOC CANCER RESEARCH.
2020 Mah, C. Y., Nassar, Z. D., Burvenich, I. J., Irani, S., Centenera, M. M., Moldovan, M., . . . Butler, L. M. (2020). DECR1: The rate limiting enzyme of polyunsaturated fatty acid metabolism and a novel therapeutic target in prostate cancer. Poster session presented at the meeting of CANCER RESEARCH. ELECTR NETWORK: AMER ASSOC CANCER RESEARCH.
2020 Shrestha, R. K., Townley, S., Hanson, A., Pickering, M., Nassar, Z. D., Mah, C. Y., . . . Selth, L. A. (2020). ACSM1 and ACSM3 regulate fatty acid oxidation in prostate cancer to promote growth and protect against oxidative stress.. Poster session presented at the meeting of CANCER RESEARCH. ELECTR NETWORK: AMER ASSOC CANCER RESEARCH.
WoS1
Grants and Fellowships
CURRENT FELLOWSHIP
- Cancer Council SA Beat Cancer Project Early Career Research Fellowship (part funded by SAiGENCI). MAH CY. 2023-2025. $480,000.
PREVIOUS FELLOWSHIP
- Prostate Cancer Foundation of Australia Priority Impact Research Award - Future Leaders. MAH CY. 2022-2023. $100,000.
CURRENT GRANTS
- The Hospital Research Foundation Innovations in Men's Health Project Grant. MAH CY, Centenera MM, Butler LM, Lynn DJ. 2023-2024. $125,000.
-
Australian Federation of University Women SA Inc. Trust Postdoctoral Grants. MAH CY. 2023. $5,000.
Travel Funding
| Year | Source | Amount |
|---|---|---|
| 2019 | Adelaide Medical School Research Travel Awards, University of Adelaide | $3,000 |
| 2018 | Adelaide Medical School Research Travel Awards, University of Adelaide | $1,000 |
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2023 Co-Supervisor The impact of high fat diet on plasma ceramides and prostate tumour metastasis Doctor of Philosophy Doctorate Full Time Miss An Dieu Trang Nguyen -
Other Supervision Activities
Date Role Research Topic Location Program Supervision Type Student Load Student Name 2023 - ongoing Co-Supervisor The Effect of Diet on Prostate Cancer Progression University of Adelaide Doctor of Philosophy Doctorate Full Time An Dieu Trang Nguyen 2022 - ongoing Co-Supervisor Targeting Fatty Acid Metabolism in Advanced Prostate Cancer The University of Adelaide - Honours Full Time An Dieu Trang Nguyen 2020 - ongoing Co-Supervisor Targeting Fatty Acid Metabolism in Prostate Cancer University of Adelaide Adelaide Medical School Honours Full Time Takuto Nijiima
-
Committee Memberships
Date Role Committee Institution Country 2021 - ongoing Board Member Australian Society for Medical Research SA State Committee Australian Society for Medical Research Australia 2021 - 2021 Convener EMBL Australia Postgraduate Symposium EMBL Australia Australia 2020 - ongoing President Health Sciences Postgraduate Association (HeSPA) The University of Adelaide Australia 2018 - 2018 Member 2018 ABCABS conference/COMBINE symposium National Program Committee ABCABS Australia -
Memberships
Date Role Membership Country 2022 - ongoing Representative European Association for Cancer Research United Kingdom 2020 - ongoing Member American Association for Cancer Research (AACR) United States 2019 - ongoing Member Australian Society for Medical Research Australia 2017 - ongoing Member Australian Bioinformatics And Computational Biology Society Australia 2017 - ongoing Member Freemasons Centre for Male Health and Wellbeing Australia
Connect With Me
External Profiles
